In recent years, atmospheric cold plasma (ACP) has been widely investigated for potential application as an alternative decontamination technology in biomedical and healthcare sectors. In this study, the antimicrobial efficacy of ACP against Pseudomonas aeruginosa biofilms was investigated. The 48-h biofilms were treated inside sealed polypropylene containers with a high-voltage dielectric barrier discharge (DBD) ACP (80 kV RMS ) and subsequently stored for 24 h at room temperature. Treatment for 60 s by either the direct or indirect mode of ACP exposure (inside or outside plasma discharge, respectively) reduced bacterial populations by an average of 5.4 log cycles from an initial 6.6 log 10 CFU/mL. Increasing the treatment time from 60 s to 120 s and 300 s reduced biofilms to undetectable levels. According to XTT assay (a metabolic activity assay), an extended treatment time of 300 s was necessary to reduce metabolic activity of cells in biofilms by an average of 70%. Further investigation of biofilm viability by confocal laser scanning microscopy (CLSM) and scanning electron microscopy (SEM) demonstrated that extended ACP treatment had a detrimental effect on the viability of P. aeruginosa through disintegration of both bacterial cells and the biofilm matrix. The results of this study demonstrate the potential of a novel, in-package, high-voltage ACP decontamination approach for the inactivation of bacterial biofilms.
I. INTRODUCTION
Pseudomonas aeruginosa is one of the most abundant microorganisms in the natural environment and is a common opportunistic nosocomial pathogen, which causes a wide variety of acute and persistent infections in immunocompromised patients. This microorganism has become increasingly important due to associated prevalence, pathogenicity, and increasing resistance to antimicrobial treatments, causing morbidity and mortality. [1] [2] Pseudomonas associated health care infections include respiratory tract infections, [3] [4] urinary tract infections, 5 surgical and burn wound infections 6, 7 and bloodstream infections. 8, 9 According to Neonatal Infection Surveillance Network, between 2005 and 2011, in the United Kingdom, Pseudomonas spp. were responsible for 93% of neonatal infection outbreaks and with 18% of associated deaths.
Water is the main environmental reservoir of P. aeruginosa, and the water distribution system is one of the possible sources of P. aeruginosa in healthcare settings (taps, sinks, etc.). 2, 11 In addition, P. aeruginosa has a tendency to form biofilms. Recently, Walker et al. 12 demonstrated that, within hospital facilities in Northern Ireland, P. aeruginosa exists predominantly in the form of biofilm in water tap outlets, which are therefore a possible cause of infection. Biofilms are broadly described as a microbially derived sessile community with altered phenotype with respect to growth rate, in which cells are attached to a substratum or to each other and are embedded in a matrix of extracellular polymeric substances (EPSs). 13 Material secreted by bacteria EPS (i.e., polysaccharides, proteins, lipids, and nucleic acids) act as a complex defensive mechanism protecting bacteria from unfavourable environmental conditions. Due to the heterogeneous nature and multiple mechanisms of resistance, biofilms have an enormous impact on medicine.
14 It has been estimated that up to 80% of human bacterial infections are associated with biofilms. 15 Once biofilms are established, different mechanisms account for resistance to antimicrobial treatments. In addition, inappropriate use or overuse of antibiotics may also result in increased bacterial resistance. 16, 17 Therefore, alternative antimicrobial measures are required as a key component of the prevention of healthcare-associated infections (HAIs) to ensure effective reductions and elimination of pathogens and their associated biofilms while simultaneously averting bacterial resistance.
Atmospheric cold plasma (ACP) technology is an innovative field that is intensively researched for a range of different medical applications. Von Woedtke et al. 18 classified plasma for medical application according to two general principles: indirect use of plasma to treat surfaces, materials, or devices for medical applications, and application of physical plasma on or within the human body. Sterilization of medical materials or devices (e.g., medical implants, catheters, or materials in blood purification systems) is the main use of indirect plasmas for medical purposes; 20 whereas physical plasmas are under intense study for applications in wound healing, 19, 20 blood coagulation and skin regeneration, 21 dentistry, 22 and apoptosis of cancer cells. 23 To date, research on ACP sterilization has demonstrated effective reduction of clinically important microorganisms in their planktonic state or in biofilms. 24, 25 However, the antimicrobial effects of plasma were reduced against biofilms by comparison with their planktonic counterparts. [26] [27] The aim of this study was to evaluate the potential of novel, in-package, high-voltage air DBD ACP for elimination of P. aeruginosa biofilm. The effects of treatment time and mode of plasma exposure were investigated. Surviving bacterial populations in biofilm were estimated by colony count and XTT (2,3-bis (2-methoxy-4-nitro-5-sulfophenyl) [phenyl-amino)car-bonyl]-2H-tetrazolium hydroxide) assays for determination of cell viability and metabolic activity, respectively. The ability of the contained ACP reactive species to penetrate complex biofilm structures was observed using a LIVE/DEAD bacterial viability kit followed by confocal scanning laser microscopy (CSLM). Scanning electron microscopy (SEM) was conducted to observe morphological changes of biofilms caused by ACP treatment.
II. MATERIALS AND METHODS

A. Bacterial Strains and Inocula Preparation
Pseudomonas aeruginosa ATCC 27853, a blood culture isolate, was obtained from the microbiology stock culture of the School of Food Science and Environmental Health of the Dublin Institute of Technology and was utilized in all experiments. A single isolated colony of the culture was inoculated in tryptic soy broth without glucose [TSB (-G), ScharlauChemie, Spain] and was incubated at 37°C for 18 h. The overnight culture was diluted in TSB to a density of 7.0 log 10 colony-forming units per milliliter (CFU/mL), using the McFarland standard. This bacterial cell concentration was further used as an inoculum for biofilm formation.
B. Biofilm Formation
Bacterial biofilms were produced in either 96-well plates for the colony count and XTT assay, on glass coverslips (24 x 32 mm) for CLSM analysis, or using tissue culture-treated inserts containing polycarbonate membrane (0.45 µm, Millicell, Millipore, Ireland) for SEM analysis. Biofilms in the 96-well plates were obtained by adding 200 µl of TSB bacterial suspension (7.0 log 10 CFU/ml) to the wells of the plates. For production of biofilms for CLSM, coverslips were positioned inside the wells of the 6-well culture plate, and 8 ml of TSB bacterial suspension was added. For production of biofilms on polycarbonate membranes, inserts were placed inside the wells of the 6-well plate, which were filled with 2 ml of TSB bacterial suspension. The plates were incubated at 37°C for 48 h. After 24 h of incubation, the supernatant from each well of the 96-well and 6-well plates containing inserts or glass coverslips was replaced with fresh TSB, with further incubation for 24 h. After incubation, the TSB containing suspended bacterial cells was removed and the wells were extensively rinsed with sterile PBS, leaving only bacterial biofilms for further investigation. Negative controls were obtained using TSB without inocula. Prior to each experiment, the biofilms were air dried for 60 min.
C. Experimental Design
The ACP system utilized a high-voltage DBD system previously described in Ziuzina et al. 28 with a maximum voltage output of 120 kV at 50 Hz. The distance between the two 15-cm diameter aluminium disk electrodes was 22 mm, which was equal to the height of the polypropylene container (310 x 230 x 22 mm) utilized as both a sample holder and as a dielectric barrier. For this study, ACP was generated in air at 80 kV RMS .
The 96-well plates, glass coverslips or membrane inserts containing biofilms were placed in the center of the plastic container directly between the electrodes within the plasma discharge for direct plasma treatment (Fig. 1A) . For indirect plasma treatment, a separate container was used, and either substrate containing biofilm was placed to achieve treatment outside the plasma discharge (Fig. 1B) . After sample loading, each container was sealed with a high-barrier polypropylene bag (Cryovac, B2630, USA) and placed between the aluminium electrodes of the transformer. The biofilms were treated with direct/indirect ACP for 0, 60 s, 120 s, and 300 s and were subjected to a post-treatment storage for 24 h at room temperature. Control samples were untreated. All experiments involving biofilm formation in 96-well plates were conducted using three independently grown cultures and were repeated at least twice. Experiments were repeated three times when biofilms were grown on glass coverslips and membrane inserts. 
D. Biofilm Assays
Crystal violet assay (CV)
Crystal violet (CV) staining was used to monitor biofilm formation capacity using 24 h and 48 h incubation times. Biofilm mass was quantified as described previously.
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The absorbance was measured at 590 nm on a microplate reader (Synergy HT, Biotek Instruments, Inc.). Each absorbance value was corrected by subtracting the means of absorbance of a blank (uninoculated) TSB. Experiments were carried out in triplicate and were repeated at least twice.
Colony count assay
Following ACP treatment and 24 h post treatment storage, 200 µl of sterile PBS was added into the biofilm containing wells of the 96-well plate. To disrupt biofilms, the plates were sonicated using a water table sonicator (Bransonic 5510E-MT, Branson, USA) for 5 min. Suspensions were pooled together from the wells into sterile Eppendorf tubes, serially diluted in maximum recovery diluent (MRD, ScharlauChemie, Spain), if necessary, and 0.1-mL aliquots of appropriate dilutions were surface plated on TSA and incubated at 37°C for 24 h. Results are presented as surviving bacterial population in log 10 CFU/mL units.
XTT assay
Prior to each assay, fresh solution of 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl) [phenyl-amino)car-bonyl]-2H-tetrazolium hydroxide (XTT, 1 mg/ml, Sigma-Aldrich, Ireland) was prepared as described previously. 32 The wells containing biofilms and negative controls (TSB without inocula) were filled with sterile PBS (100 µl), then XTT-menadione (100 µl) was added to all wells. Plates were incubated for 5 h at 37°C in the dark. After incubation, the supernatant (100 µl) from each well was transferred into the wells of a new 96-well microtiter plate, and the absorbance was measured at 486 nm on a microplate reader. The percentage of the surviving bacterial population was calculated as ((A ACP -A C ) / A 0 ) × 100%, where A ACP , A C , and A 0 are the absorbance of ACP treated, the negative control, and untreated control biofilms, respectively.
Confocal laser scanning microscopy (CLSM)
Prior to analysis, to differentiate viable and dead bacteria, untreated controls and biofilms treated with either direct or indirect ACP for 300 s were stained using a LIVE/DEAD bacterial viability kit containing SYTO9 and propidium iodide (PI) (Sigma-Aldrich, Ireland). Biofilms grown on glass coverslips were covered with 200 µL of SYTO9, and the PI solution was prepared according to the manufacturer's instructions and was incubated for 15 min in the dark. The samples were rinsed with sterile deionized water, placed on the microscope glass slide, and imaged using a Zeiss confocal microscope (Carl Zeiss, Model: LSM 510, Germany). The quantitative parameters to characterize biofilm thickness were obtained from CLSM stack images and the sample images were further analyzed by IMARIS image analysis software (Bitplane, Inc.). The maximum thickness of the biofilm was determined from the value of the Y-axis.
Scanning electron microscopy (SEM)
For SEM analysis, untreated controls and P. aeruginosa biofilms treated directly or indirectly with ACP for 300 s were selected and prepared as described by Gratao et al., 30 with minor modifications. The cells were fixed in ice-cold 2.5% glutaraldehyde in 0.05 M sodium cacodylate buffer (pH 7.4) (SCB) for 2 h. The cells were washed with the same buffer three times and were then fixed in 1% osmium tetroxide for 2 h at 4°C. After 2 h of fixation, bacterial cells were washed with SCB followed by three washes with distilled water. The samples were treated using increasing concentrations of ethanol (30%, 50%, 70%, 80%, 95%, and 99.5%) and dehydrated as described by Srey et al.
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using 33%, 50%, 66%, and 100% (v/v) hexamethyldisilazane (Sigma-Aldrich, Ireland). To prevent surface charging by the electron beam, the samples were sputter-coated with gold particles using Emitech K575X Sputter Coating Unit resulting in a coating of 10 nm after 30 s. The samples were examined visually using a FEI Quanta 3D FEG Dual Beam SEM (FEI Ltd, Hillsboro, USA) at 5 kV.
E. Statistical Analysis
Statistical analyses were performed using SPSS 19.0 (SPSS, Inc., Chicago, USA). The surviving populations of P. aeruginosa biofilms following ACP treatments were compared using analysis of variance (ANOVA). Means were compared according to the method of Fisher's least significant difference (LSD) at the 0.05 level.
III. RESULTS
A. Evaluation of Biofilm Biomass by CV Assay
According to the scheme described by Stepanovic et al., 32 24-h-and 48-h-old P. aeruginosa demonstrated strong ability to produce biofilms ( Fig. 2A) . Notably, after 48 h of incubation, P. aeruginosa biofilms were clearly visible on the surface of the wells of the 96-well microtiter plate (Fig. 2B) . Based on these results, only bacterial biofilms grown for 48 h were used in further studies aimed at investigating the efficacy of ACP to inactivate bacteria in not only the realistic but also the more resistant biofilm form.
B. Effects of ACP on P. aeruginosa biofilms Assessed by Colony Count and XTT Assays
The influence of ACP treatment time and mode of exposure on viability of P. aeruginosa biofilms based on colony count assay is presented in Fig. 3A . Generally, both direct and indirect modes of plasma exposure effectively reduced bacterial populations in biofilms after short treatment times. Prior to ACP treatment, an average population of bacterial biofilm attached on the surface of the wells was 6.6 log 10 CFU/mL. ACP treatment for 60 s reduced bacterial cells by an average of 5.4 log 10 CFU/mL; increasing treatment time to 120 s and 300 s reduced the numbers of viable cells within the biofilms to levels below detection limits (1.0 log 10 CFU/mL). Percentage survival of P. aeruginosa biofilm after ACP exposure based on XTT assay is presented in Fig. 3B . XTT absorbance values demonstrated that 60 s of direct and indirect treatment reduced metabolic activity of cells by 37% and 49%, respectively. Increasing treatment time from 60 s to 120 s further reduced cell metabolic activity by 63% and 70% when exposed to direct and indirect treatment, respectively. However, no further reductions were observed by applying extended treatment time of 300 s, with a maximum average reduction of 70% recorded. Notably, post treatment storage time of 24 h had a minor effect on biofilm activity for this microorganism based on both colony count and XTT assays.
C. Confocal Laser Scanning Microscopy (CLSM)
To evaluate the effect of ACP on viability of bacterial cells embedded in biofilm structures, CLSM analysis of untreated control and P. aeruginosa biofilms treated directly/ indirectly for 300 s was conducted. This analysis utilizes the mixture of SYTO9 (green fluorescent) and PI (red fluorescent) nucleic acid dyes. SYTO9 labels bacterial cells with both intact and damaged membrane, whereas PI penetrates only cells with damaged membrane. Therefore, this analysis allows determination of bacterial viability and cell membrane integrity on the basis of different colors, where green and red represent live and dead cells, respectively. The results of the CLSM analysis are presented in Fig. 4 . As can be seen from Fig. 4A , the untreated control sample exhibited completely green fluorescence, i.e., only live cells were present. Maximum biofilm thickness of 23 µm was recorded. Confocal images of biofilms treated with either direct or indirect ACP (Fig. 4B, 4C , respectively) displayed only red fluorescence, with no viable cells remaining after treatment. Moreover, images of ACP-treated samples also indicated a substantial reduction of biofilm thickness when compared with control biofilms. The thickness of biofilms was reduced to 8 µm and 6 µm after direct and indirect ACP treatment, respectively.
D. Scanning Electron Microscopy (SEM)
To examine the effects of ACP on P. aeruginosa biofilm distribution and morphology, SEM analysis of untreated control and samples treated directly or indirectly for 300 s was conducted. Figure 5A and indirect ACP treatments. Complete disintegration of cells and biofilm matrix was noted after direct ACP treatment: biofilms were converted into the 'sponge-like,' irregularly shaped debris compared with untreated controls (Fig. 5B ). Although indirect ACP had similar destructive effects on biofilm structures, small fractions of EPS components were still detected after the treatment (Fig. 5C ).
IV. DISCUSSION
In recent years, cold atmospheric plasma (ACP) has been widely investigated as an alternative sterilization technology for potential application in medicine. This technology has been demonstrated to have great bactericidal effects against a wide range of microorganisms with high potential to avoid any thermal damage to both living and non-living biomedical structures. 33 Our previous studies demonstrated that high-voltage DBD ACP in conjunction with treatment of contaminated objects inside sealed packages and following post treatment storage was very effective for inactivation of bacteria in their planktonic form, reducing the numbers within seconds. 31 However, bacterial biofilms, as a predominant mode of microbial growth, 34 represent major challenges in industrial and health care settings due to their increased mechanical stability and antimicrobial resistance. 35 Therefore, in the present study, the potential of ACP to inactivate bacterial pathogens was investigated against challenge P. aeruginosa biofilms, as one of the major causes of healthcare-associated infections.
P. aeruginosa is considered a model microorganism for biofilm research due to its excellent ability to form biofilm. 36 Because bacteria in older biofilms are more resistant to antimicrobial treatments, 37, 38 only biofilms grown for 48 h were utilized to present a realistic challenge to the ACP treatment. The effect of ACP treatment on P. aeruginosa biofilms was investigated utilizing widely accepted plate-count and XTT assays. According to the results obtained from both assays, no significant difference between the effects of direct and indirect modes of exposure on bacterial biofilms was found. According to colony counts, rapid inactivation of cells in biofilm was achieved after relatively short treatments (60 s), resulting in reduction of bacterial levels by 5.4 log 10 CFU/ml. With lower inactivation rates, however, bacterial populations were below detection limits after exposure to 120 s and 300 s of treatment. Similarly, Alkawareek et al. 39 reported biphasic reductions of P. aeruginosa biofilms due to ACP treatment, where initial 60 s of plasma treatment resulted in rapid decline in bacterial levels, causing slower reduction between 60 s and 240 s of treatment. In general, our data suggest that 80kV air in-package DBD ACP treatment exhibits considerably high inactivation potential against the most abundant and resistant bacterial form-biofilm. Notably, based on our preliminary data, treatment for only 30 s was required to completely eliminate P. aeruginosa (~7.0 log 10 CFU/ml reduction) in the planktonic form (data not shown). In general, according to previous reports, focusing on inactivation efficacy of ACP against biofilm, complete inactivation of P. aeruginosa biofilm could be achieved after longer treatment times, from 5 to 10 min. 27, 40 Utilization of different ACP systems and different approaches to biofilm formation are probably the main reasons for variations in the published reports, which reduces the possibility of drawing adequate conclusions regarding the overall plasma treatment effectiveness against bacterial biofilms. Comprehensive system, process, and target comparative studies are still required.
To examine the effects of ACP on the metabolic state of P. aeruginosa biofilms, the XTT assay was utilized, which involves intracellular reduction of XTT to a water-soluble formazan, the absorbance of which is proportional to the number of metabolically active bacterial cells. 32 This method has been successfully utilized to measure the respiratory activity of bacteria after application of different sanitizers as well as ACP. 27, 41 According to the results obtained from the XTT assay, even after extended treatment time of 300 s, an average of 30% of cells in biofilms were still metabolically active. This outcome was also observed by Alkawareek et al., 42 who reported that ACP inactivated 85% of P. aeruginosa cells according to colony counts, while the XTT absorbance value corresponded to 36%. Borges et al. 42 observed similar bacterial response to stress, when P. aeruginosa biofilm was subjected to naturally derived compounds with 30% of cell metabolic activity remaining after the treatment. In general, the plate count assay accounts only for culturable bacterial cells and does not take into account cells that might still be metabolically active. Bacteria that fail to grow on the bacteriological media but are still alive are described as a viable but nonculturable (VBNC) state of bacteria. This result has been demonstrated for many microorganisms when facing environmental stress, including P. aeruginosa. 43, 44 Bacteria in a VBNC state can regain culturability and can retain virulence, even when they are in the nonculturable state. Therefore, VBNC bacteria may contribute to further contamination. 45 CLSM, in conjunction with nucleic acid dyes SYTO9 and PI, was used to evaluate the effects of ACP treatment on viability and cell membrane integrity. Microscopic observations demonstrated that the bacterial cell membrane was completely ruptured following treatment, which indicates the potential destruction abilities of the high-voltage system used. Although high sterilization potential is among the main characteristics and advantages of every antimicrobial technique, physical removal of bacterial biofilms is another important criteria that is gaining increased attention, specifically in plasma biofilm research. Confocal microscopy analysis also demonstrated that ACP treatment was able not only to successfully inactivate cells through penetration inside complex bacterial aggregates but also to substantially remove the biofilm from the associated surface, which was identified by measuring the biofilm thickness.
The results of this work also point to the complex interaction between reactive species generated by air plasma and biofilms. As is commonly known, air plasma is an excellent source of electrons and positive and negative ions, free radicals, stable conversion products (e.g., ozone), excited atoms and molecules, and ultraviolet radiation photons. 46 The main mechanism of action of ACP reactive species is the diffusion of oxygen species through the bacteria cell wall, which causes local damage to the cytoplasmic membrane, protein and DNA strands, as well as physical effects by causing microbial etching and erosion. 47, 48 In this study, to monitor the physical changes caused by ACP treatment, SEM analysis of biofilms was conducted. The microscopic images enabled observation of the differences between control (untreated) samples, which proved biofilm complexity and the resulting challenge linked to antimicrobial resistance, and treated samples, where cells and biofilm components were significantly damaged by the action of ACP.
Notably, the in-package, high-voltage ACP treatment used a 24-h post treatment storage time. This allowed the retention of plasma reactive species inside the pack over time, thus facilitating bactericidal action of these species on biofilm samples. This approach is more likely to show increased antimicrobial effects of plasma, the mechanism of which is mainly based on the reaction of long-lived and recombined species rather than on charged particles or short-lived species, which are more relevant to effects noted using treatment without post treatment storage. This approach could contribute to an increased potential of plasma species to penetrate complex biofilm matrices further inactivating the cells. However, there are several limitations in this work. It is known that formation of biofilms is influenced by environmental conditions and characteristics of substrates to which bacteria attach. In this study, the model system, a 96-well microtiter plate, was utilized for biofilm development, which cannot holistically describe the broad range of materials implicated in biofilm formation within clinical environments. Moreover, it is more likely that, in real clinical environments, biofilm communities may be inhabited by numerous different species and that interactions among these species could contribute to the organization of multispecies biofilms. Multispecies biofilms are usually more resistant against antimicrobial treatments than monospecies biofilms. 49 Therefore, further studies on the efficacy of ACP against multispecies biofilms developed on a wider range of relevant materials may be warranted.
IV. CONCLUSION
The results of this study clearly demonstrate that in-package, high-voltage air DBD ACP in conjunction with post treatment storage is very effective against complex bacterial biofilms. With relatively short treatment of 60 s, it was possible to achieve substantial Volume 4 Numbers 1-4, 2014 reductions (5.4 log 10 CFU/ml) of 48-h-old P. aeruginosa biofilms. In this study, a series of methods were utilized to monitor the changes in biofilms caused by ACP treatment, namely, colony count, XTT assay, CLSM, and SEM, elucidating information regarding different parameters associated with the viability of cells in biofilms. In terms of metabolic activity, 30% of cells survived extended treatment for 300 s, whereas, according to colony count, there were no bacterial survivors. These results indicate a possible induction of VBNC state of bacteria due to the stress caused by ACP treatment. However, CLSM and SEM analyses indicate that extended treatment caused severe damage to P. aeruginosa cell membranes and effectively disrupted heterogeneous biofilm structures. However, better understanding of interactions between plasma ACP reactive species and biofilm components and identification of specific biofilm targets will allow further optimization of ACP treatment parameters toward more effective and less damaging sterilization required in the field of medicine.
